AGTX
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Oct 3 closing price
Capitalization
1.86M
RLAY
Price
$5.48
Change
+$0.26 (+4.98%)
Updated
Oct 3 closing price
Capitalization
944.81M
30 days until earnings call
Interact to see
Advertisement

AGTX vs RLAY

Header iconAGTX vs RLAY Comparison
Open Charts AGTX vs RLAYBanner chart's image
Agentix
Price$0.05
Change-$0.00 (-0.00%)
Volume$20K
Capitalization1.86M
Relay Therapeutics
Price$5.48
Change+$0.26 (+4.98%)
Volume$1.56M
Capitalization944.81M
AGTX vs RLAY Comparison Chart in %
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGTX vs. RLAY commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTX is a StrongBuy and RLAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (AGTX: $0.05 vs. RLAY: $5.48)
Brand notoriety: AGTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGTX: 82% vs. RLAY: 95%
Market capitalization -- AGTX: $1.86M vs. RLAY: $944.81M
AGTX [@Biotechnology] is valued at $1.86M. RLAY’s [@Biotechnology] market capitalization is $944.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGTX’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • AGTX’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGTX and RLAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGTX’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • AGTX’s TA Score: 4 bullish, 3 bearish.
  • RLAY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AGTX is a better buy in the short-term than RLAY.

Price Growth

AGTX (@Biotechnology) experienced а +12.76% price change this week, while RLAY (@Biotechnology) price change was +6.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($945M) has a higher market cap than AGTX($1.87M). RLAY YTD gains are higher at: 33.010 vs. AGTX (-72.424). AGTX has higher annual earnings (EBITDA): -545.9K vs. RLAY (-338.15M). RLAY has more cash in the bank: 657M vs. AGTX (4.41K). AGTX has less debt than RLAY: AGTX (343K) vs RLAY (34.2M). RLAY has higher revenues than AGTX: RLAY (8.36M) vs AGTX (0).
AGTXRLAYAGTX / RLAY
Capitalization1.87M945M0%
EBITDA-545.9K-338.15M0%
Gain YTD-72.42433.010-219%
P/E RatioN/AN/A-
Revenue08.36M-
Total Cash4.41K657M0%
Total Debt343K34.2M1%
FUNDAMENTALS RATINGS
AGTX: Fundamental Ratings
AGTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGTXRLAY
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
69%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOVE0.690.06
+9.36%
Movano Inc
METC37.752.70
+7.70%
Ramaco Resources
WHWK1.960.02
+1.03%
Whitehawk Therapeutics Inc
BHB30.380.26
+0.86%
Bar Harbor Bankshares
BALL50.25-0.23
-0.46%
Ball Corp

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
+5.16%
RLAY - AGTX
32%
Poorly correlated
+4.98%
RVMD - AGTX
28%
Poorly correlated
+2.21%
SKYE - AGTX
23%
Poorly correlated
+5.79%
ALGS - AGTX
23%
Poorly correlated
-1.66%
BCYC - AGTX
22%
Poorly correlated
-1.88%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+4.98%
NRIX - RLAY
54%
Loosely correlated
+3.30%
BDTX - RLAY
54%
Loosely correlated
+4.29%
IMNM - RLAY
53%
Loosely correlated
+7.93%
RXRX - RLAY
51%
Loosely correlated
-0.54%
CRNX - RLAY
50%
Loosely correlated
-1.57%
More